Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (4): 523-528    DOI: 10.12891/ceog3951.2018
Original Research Previous articles | Next articles
Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population
M. Li1, †, L. Riming1, †, W. Zhe1, W. Hong1, H. Xiaofei1, C. Lina1, Z. Zhengfang1, W. Xuebo1, W. Ning1, S. Chengming1, *(), H. Qing-qing2, L. Hailiang2, W. Hui2
1 Center for Laboratory Diagnosis, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, Shandong, China
2 CapitalBio Genomics Co., Ltd., Dongguan, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Non-invasive prenatal screening (NIPS) using cell-free DNA is being offered to an increasing number of pregnant women. In this observational study, the authors found chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population using NIPS, and found 23 cases with NIPS high risk. They also found that the NIPS results of two cases with hysteromyoma were positive. There were 61 cases in all with maternal gynaecological tumor and the positive rate was 3.28%, which suggests that there may be a specific relationship between them and more evidence is urgently required. Among 23 cases, most had normal results with early or middle pregnancy serologic examination or ultrasonic testing. Therefore, NIPS is more accuracy and could mostly make up for regular prenatal in diagnosis. In addition, NIPS could avoid the risks such as intrauterine infection and miscarriage caused by amniocentesis karyotyping analysis, therefore, the clinical promoter of NIPS during pregnancy is very meaningful.
Key words:  Fetal aneuploidies      Non-invasive prenatal screening (NIPS)      Mixed risk factors      Pregnant women     
Published:  10 August 2018     
*Corresponding Author(s):  CHENGMING SUN     E-mail:  18953569897@163.com
About author:  † Contributed equally.

Cite this article: 

M. Li, L. Riming, W. Zhe, W. Hong, H. Xiaofei, C. Lina, Z. Zhengfang, W. Xuebo, W. Ning, S. Chengming, H. Qing-qing, L. Hailiang, W. Hui. Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 523-528.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3951.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I4/523

[1] K. Uzel, I. Lakhno. PCR positivity and D-dimer levels in pregnant women with COVID-19[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 638-644.
[2] P. Okrzymowska, M. Kurtys, N. Smolarek, M. Kurzaj, R. Slopien, K. Rozek-Piechura. Lung ventilation and the strength of the respiratory muscles of women in the third trimester of pregnancy in the aspect of physical activity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 324-328.
[3] J. Wang, T. Jiang, X. Zhu, G. Tian. Femur length in normal fetuses and the correlation between crown-rump length and gestational age at 11-14 weeks in a Chinese Han population: a preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 191-194.
[4] M.J. Kim, T.H. Kim, Y. Park, H.H. Lee, J.M. Kim, H. Lim, S.Y. Hwang. A study of the dietary intakes by the pre-pregnancy body mass index in pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 27-29.
[5] V. Papavasilopoulos, G. Bonatsos, I. Elefsiniotis, C. Birbas, P. Panagopoulos, E. Trakakis. Seroepidemiological investigation of Toxocara canis in a female Greek pregnant population in the area of Athens[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(3): 384-387.
[6] Z. Babay, J. Al Wakeel, M. Addar, A. Mittwalli, N. Tarif, D. Hammad, N. Ali, A. Al Askar, A. R. Choudhary. Serum cystatin C in pregnant women: Reference values, reliable and superior diagnostic accuracy[J]. Clinical and Experimental Obstetrics & Gynecology, 2005, 32(3): 175-179.
No Suggested Reading articles found!